T1	Participants 49 113	diabetic nephropathy patients on thiamine and pyridoxine therapy
T2	Participants 309 341	Type 2 diabetic patients (N.=57)
T3	Participants 436 465	Diabetic nephropathy patients
T4	Participants 1303 1336	type 2 diabetes mellitus patients
